|Articles|August 9, 2019
Clear Advantages for Characterizing Critical Quality Attributes (CQAs) of Biopharmaceutical Products
Author(s)Agilent
• Streamlined separations for intact proteins, peptide mapping, glycans analysis • LC/Q-TOF enhanced workflows
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
FAQ: What You Need to Know About Agentic AI in Drug Discovery
2
Coya Raises $11.1 Million to Advance Immunomodulatory ALS Program
3
AstraZeneca’s $15 Billion Investment Deepens China R&D and Manufacturing Footprint
4
FDA Priority Review of Subcutaneous Lecanemab Signals Shift in Alzheimer’s Treatment Delivery
5